针对性信息支持对乳腺癌术后患者癌症复发恐惧及疾病不确定感、应对方式的影响
|
摘要
目的探讨针对性信息支持对乳腺癌术后患者癌症复发恐惧(FCR)、疾病不确定感、应对方式的影响。方法将180例乳腺癌术后患者按入院的先后顺序分为对照组和干预组,每组90例。对照组按常规方法进行相关知识宣教,干预组实施针对性信息支持干预。分别于干预前、干预后6周采用中文版患者恐惧疾病进展简化量表(Fo P-Q-SF)评分、疾病不确定感量表(MUIS)评分、医学应对方式问卷(MCMQ)对两组患者进行评价。结果干预后,干预组患者FoP-Q-SF得分、MUIS总分、各维度得分均低于干预前,并且低于对照组(P <0. 05),对照组患者干预前后FoP-Q-SF得分、MUIS总分、不明确性、复杂性及不可预测性维度得分差异均无统计学意义(均P> 0. 05);干预后,干预组患者MCMQ的应对维度得分高于干预前及对照组,回避、屈服维度得分低于干预前及对照组(均P <0. 05)。结论针对性信息支持干预可降低乳腺癌术后患者FCR、疾病不确定感,提高应对癌症的信心及能力。
引文
[1]简国文,徐军,宋晓刚,等.乳腺癌改良根治术患者围手术期、化疗期的焦虑抑郁情绪、应对方式和生命质量的观察[J].国际精神病学杂志,2016,43(6):1 046-1 048.
[2]Herschbach P,Dinkel A.Fear of progression[J].Recent Results Cancer Res,2014,197:11-29.
[3]Frjd C,Lampic C,Larsson G.Is satisfaction with doctors'care related to health-related quality of life,anxiety and depression among patients with carcinoid tumours?A longitudinal report[J].Scand J Caring Sci,2009,23(1):107-116.
[4]王蓉,侯爱和.信息支持对癌症化疗患者生活质量及应对方式的影响[J].护理学杂志,2013,28(19):47-50.
[5]Mehnert A,Herschbach P,Berg P,et al.Fear of progression in breast cancer patients--validation of the short form of the Fear of Progression Questionnaire(Fo P-Q-SF)[J].Z Psychosom Med Psychother,2006,52(3):274-288.
[6]吴奇云,叶志霞,李丽,等.癌症患者恐惧疾病进展简化量表的汉化及信效度分析[J].中华护理杂志,2015,50(12):1 515-1 519.
[7]Mishel MH.The measurement of uncertainty in illness[J].Nurs Res,1981,30(5):258-263.
[8]Feifel H,Strack S,Nagy VT.Coping strategies and associated features of medically ill patients[J].Psychosom Med,1988,49(6):616-625.
[9]沈晓红,姜乾金.医学应对方式问卷中文版701例测试报告[J].中国行为医学科学,2000,9(1):18-20.
[10]张阳,田丽,高月乔,等.癌症患者复发恐惧的研究进展[J].中华护理杂志,2017,52(8):997-1 001.
[11]陈志玲,江锦芳,曾珊,等.聚焦解决模式对癌症化疗患者负性情绪和应对方式的影响[J].实用临床医药杂志,2016,20(14):167-169.
[12]张阳,田丽,王盼盼,等.乳腺癌患者癌症复发恐惧及影响因素分析[J].广东医学,2017,38(23):3 658-3 661.
[13]Wu WW,Tsai SY,Liang SY,et al.The mediating role of resilience on quality of life and cancer symptom distress in adolescent patients with cancer[J].J Pediatr Oncol Nurs,2015,32(5):304-313.
[14]Min JA,Yoon S,Lee CU,et al.Psychological resilience contributes to low emotional distress in cancer patients[J].Support Care Cancer,2013,21(9):2 469-2 476.
[15]王婷婷,李冬,王辉,等.胃癌化疗患者的疾病不确定感、应对方式与生活质量的相关性分析[J].中国临床研究,2016,29(10):1 434-1 437.
[16]Sarkar S,Scherwath A,Schirmer L,et al.Fear of recurrence and its impact on quality of life in patients with hematological cancers in the course of allogeneic hematopoietic SCT[J].Bone Marrow Transplant,2014,49(9):1 217-1 222.
[2]Herschbach P,Dinkel A.Fear of progression[J].Recent Results Cancer Res,2014,197:11-29.
[3]Frjd C,Lampic C,Larsson G.Is satisfaction with doctors'care related to health-related quality of life,anxiety and depression among patients with carcinoid tumours?A longitudinal report[J].Scand J Caring Sci,2009,23(1):107-116.
[4]王蓉,侯爱和.信息支持对癌症化疗患者生活质量及应对方式的影响[J].护理学杂志,2013,28(19):47-50.
[5]Mehnert A,Herschbach P,Berg P,et al.Fear of progression in breast cancer patients--validation of the short form of the Fear of Progression Questionnaire(Fo P-Q-SF)[J].Z Psychosom Med Psychother,2006,52(3):274-288.
[6]吴奇云,叶志霞,李丽,等.癌症患者恐惧疾病进展简化量表的汉化及信效度分析[J].中华护理杂志,2015,50(12):1 515-1 519.
[7]Mishel MH.The measurement of uncertainty in illness[J].Nurs Res,1981,30(5):258-263.
[8]Feifel H,Strack S,Nagy VT.Coping strategies and associated features of medically ill patients[J].Psychosom Med,1988,49(6):616-625.
[9]沈晓红,姜乾金.医学应对方式问卷中文版701例测试报告[J].中国行为医学科学,2000,9(1):18-20.
[10]张阳,田丽,高月乔,等.癌症患者复发恐惧的研究进展[J].中华护理杂志,2017,52(8):997-1 001.
[11]陈志玲,江锦芳,曾珊,等.聚焦解决模式对癌症化疗患者负性情绪和应对方式的影响[J].实用临床医药杂志,2016,20(14):167-169.
[12]张阳,田丽,王盼盼,等.乳腺癌患者癌症复发恐惧及影响因素分析[J].广东医学,2017,38(23):3 658-3 661.
[13]Wu WW,Tsai SY,Liang SY,et al.The mediating role of resilience on quality of life and cancer symptom distress in adolescent patients with cancer[J].J Pediatr Oncol Nurs,2015,32(5):304-313.
[14]Min JA,Yoon S,Lee CU,et al.Psychological resilience contributes to low emotional distress in cancer patients[J].Support Care Cancer,2013,21(9):2 469-2 476.
[15]王婷婷,李冬,王辉,等.胃癌化疗患者的疾病不确定感、应对方式与生活质量的相关性分析[J].中国临床研究,2016,29(10):1 434-1 437.
[16]Sarkar S,Scherwath A,Schirmer L,et al.Fear of recurrence and its impact on quality of life in patients with hematological cancers in the course of allogeneic hematopoietic SCT[J].Bone Marrow Transplant,2014,49(9):1 217-1 222.